logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Could erectile dysfunction in type 2 diabetes change the presumption of normative total blood serum testosterone?

[Surgery]
Michail Kogan; Igor Belousov; Irina Khripun; Sergey Vorobyev; Halid Ibishov; Elizaveta Dzantieva; Artur Cherniy;

According to research data, the ED is detected in 50–75 % of men with T2DM. During the last decade, the problem of ED in the presence of late onset hypogonadism has been actively studied. There is convincing proof that total serum testosterone (T) deficit influences the development and severity of ED, including in T2DM. The principal aim of the current study was to evaluate ED in males with T2DM at low and middle-to-high normative levels of T.

We have performed a prospective randomized simple comparative study of 86 male patients with T2DM and T level higher than 12.0 nmol/l. The patients were divided into two groups, with low normative level of T and with middle – to high normative T levels. Standard methods of objective evaluation did not permit discrimination in the T2DM compensation. At the same time the diseases based on vascular pathology, dyslipidemia and vascular endothelial dysfunctions were more frequently found in patients with middle-to-high normal T levels. In the two groups of patients the severity of androgen deficiency symptoms was found out to be unequal. The IIEF-5 questionnaire showed significant difference in frequency and severity of ED and significant relation to T levels. Males with T2DM and normotestosteronemia at 12–15 mmol/l are at higher risks of dyslipidemia, endothelium disorders and progress of T2DM as compared to males with blood T of>15 mmol/l.

Download

References:
1. Chazova I. E., Ratova L. G., Bojcov S. A., Nebieridze D. V. Diagnostics and treatment of arterial hypertonia (Recommendations of Russian medical society for arterial hypertonia and All-Russia scientific society of cardiologists). Sistemnye gipertenzii. – System hypertensias. 2010;3:5-26.
2. Lupinskaja Z. A. Vascular endothelium – principal regulator of local blood. Vestnik KRSU. – KRSU newsletter. 2003;3(7):15-21.
3. Metel’skaja V. A., Gumanova N. G. Nitric oxide: part in regulation biological functions, methids of detection in human blood. Laboratornaja medicina. – Laboratory medicine. 2005;7:19-24.
4. Petunina N. A., Al’tshuler N. Je. A comparative analysis of adiponectine, leptine, resistine, lipid metabolism indicators and insuin resistance in subclinical hypothyreosis depending on presence or absence of replacement herapy with levothyroxine. Consilium medicum. – Consilium medicum. 2013;15(4):12-15.
5. Zatejshhikov D. A., Minushkina L. O., Kudrjashova O. Ju. Functional condition of endothelium in patients with arterial hypertonia and ishemic heart disease. Kardiologija. – Сardiology. 2000;6:14-17.
6. Jellinger P., Smith D., Mehta A., Ganda O., Handelsman Y. et al. Endocrine Practice. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. 2012;18(1):1-78.
7. El Saghier E. O., Shebl S. E., Fawzy O. A., Eltayeb I. M., Lamya M. A. et al. Androgen deficiency and erectile dysfunction in patients with type 2 diabetes. Clin. Med. Insights Endocrinol. Diabetes. 2015;19(8):55-62.
8. Skeldon S. C., Detsky A. S., Goldenberg S. L., Law M. R. Erectile Dysfunction and Undiagnosed Diabetes, Hypertension, and Hypercholesterolemia. Ann. Fam. Med. 2015;13(4):331-335.
9. Dhindsa S., Prabhakar S., Sethi M., Bandyopadhyay A., Chaudhuri A. et al. Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 diabetes. Clin. Endocrinol. Metabol. 2004;89(11):5462-5468.
10. Sacks D. B., Arnold M., Bakris G. L., Bruns D. E., Horvath A. R. et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;34(6):61-99.
11. Hadeed N. N., Thanoon I. A., Al-Mukhtar S. B. Total testosterone levels and the effect of sildenafil on type 2 diabetics with erectile dysfunction. Oman Med J. 2014.;29(1):46-50.
12. Hakim L. S., Goldstein I. Diabetic sexual dysfunction. Endocrinal. Metabol. Сlin. North Am. 1996;25(2):379-400.
13. Kirby M., Jackson G., Betteridge J., Friedli K. Is erectile dysfunction a marker for cardiovascular disease. Int. J. Clin Pract. 2001;55(9):614-618.
14. Laumann E., Paik A., Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537-544.
15. Liu C. C., Lee Y. C., Tsai V. F., Cheng K. H., Wu W. J. et al. The interaction of serum testosterone levels and androgen receptor CAG repeat polymorphism on the risk of erectile dysfunction in aging Taiwanese men. Andrology. 2015;3(5):902-908.
16. Mancia G., Laurent S., Agabiti-Rosei E., Ambrosioni E., Burnier M. et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertension. 2009;27(11):2121-2158.
17. Seftel A. D., Kathrins M., Niederberger C. Critical update of the 2010 Endocrine Society Clinical Practice Guidelines for male hypogonadism: a systematic analysis Mayo. Clin. Proc. 2015;90(8):1104-1115.
18. Tengblad A., Grodzinsky E., Lindström K., Mölstad S., Borgquist L. et al. Self-monitoring of blood glucose and glycaemic control in type 2 diabetes. Health Care. 2007;25(3):140-146.
19. Speel T. G., Langen H., Meuleman E. J. The risk of coronary heart disease in men with erectile dysfunction. Eur. Urol. 2003;44(3):366-371.
20. The National Academy of Clinical Biochemistry. Laboratory Medicine Practice Guidelines. 2011;1(1):1-120.

Keywords: erectile dysfunction, testosterone, type 2 diabetes mellitus


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy